Ziolkowska Agnieszka, Budzynska Katarzyna, Trejter Marcin, Tortorella Cinzia, Belloni Anna S, Malendowicz Ludwik K
Department of Histology and Embryology, Poznan School of Medicine, Poland.
Int J Mol Med. 2003 May;11(5):613-5.
Adrenomedullin (ADM) and its receptors are expressed in the adrenal cortex, where ADM is currently known to inhibit agonist-stimulated aldosterone secretion from zona glomerulosa (ZG), without affecting either basal aldosterone release or the secretory activity of zona fasciculata-reticularis (ZF/R) cells. These functional findings have been obtained using freshly dispersed adrenocortical cells, but evidence has been provided that ADM is able to enhance basal aldosterone secretion from rat capsule-ZG preparations. Hence, we investigated the effect of ADM and ADM22-52, a putative antagonist of ADM receptors, on the secretory activity of rat adrenal cell cultured in vitro for 72 h. Cultures were exposed for 3 or 24 h to 10(-7) M ADM and/or ADM22-52, in the absence or the presence of 10(-8) M ACTH, and the concentration of aldosterone and corticosterone in the culture medium was measured by radioimmune assay. ADM and/or ADM22-52 raised basal aldosterone secretion at 3 h, but not 24 h exposure, and did not affect ACTH-stimulated aldosterone production. Corticosterone secretion was not changed at 3 h. In contrast, at 24 h exposure ADM22-52 alone or with ADM decreased basal corticosterone secretion; ADM evoked a small rise in ACTH-stimulated corticosterone production, and the effect was annulled by ADM22-52. These puzzling findings are interpreted in light of the fact that i) our cultures were actually a mixture of ZG, ZF/R and medullary chromaffin cells; ii) ADM stimulates adrenomedullary cells to release catecholamines, which are able to enhance aldosterone secretion from ZG cells; and iii) the prolonged exposure to ADM may modify, under in vitro culture conditions, ZF/R cells, switching their phenotype from an ADM-unresponsive to an ADM-responsive one. Our study casts doubts on the selectivity of ADM22-52 as ADM receptor antagonist, and stresses that great caution must be used in comparing adrenal-secretion findings obtained with different in vitro techniques.
肾上腺髓质素(ADM)及其受体在肾上腺皮质中表达,目前已知ADM可抑制激动剂刺激的球状带(ZG)醛固酮分泌,而不影响基础醛固酮释放或束状带-网状带(ZF/R)细胞的分泌活性。这些功能研究结果是使用新鲜分离的肾上腺皮质细胞获得的,但有证据表明ADM能够增强大鼠被膜-ZG制剂的基础醛固酮分泌。因此,我们研究了ADM和ADM22-52(一种推测的ADM受体拮抗剂)对体外培养72小时的大鼠肾上腺细胞分泌活性的影响。培养物在不存在或存在10(-8) M促肾上腺皮质激素(ACTH)的情况下,暴露于10(-7) M ADM和/或ADM22-52 3小时或24小时,通过放射免疫分析法测定培养基中醛固酮和皮质酮的浓度。ADM和/或ADM22-52在暴露3小时时可提高基础醛固酮分泌,但在暴露24小时时则无此作用,且不影响ACTH刺激的醛固酮生成。皮质酮分泌在3小时时未发生变化。相反,在暴露24小时时,单独使用ADM22-52或与ADM一起使用可降低基础皮质酮分泌;ADM可使ACTH刺激的皮质酮生成略有增加,而ADM22-52可消除该作用。鉴于以下事实,对这些令人困惑的发现进行了解释:i)我们的培养物实际上是ZG、ZF/R和髓质嗜铬细胞的混合物;ii)ADM刺激肾上腺髓质细胞释放儿茶酚胺,而儿茶酚胺能够增强ZG细胞的醛固酮分泌;iii)在体外培养条件下,长时间暴露于ADM可能会改变ZF/R细胞,使其表型从对ADM无反应转变为对ADM有反应。我们的研究对ADM22-52作为ADM受体拮抗剂的选择性提出了质疑,并强调在比较用不同体外技术获得的肾上腺分泌结果时必须极其谨慎。